Ischaemic stroke – prevention is better than cure

This review is based on a presentation by Professor Hankey at the RCPE Neurology Symposium on 27 November 2009.

Keywords Evidence, health policy, ischaemic stroke, prevention, randomised trials, treatment

Declaration of Interests Professor Hankey has received honoraria for speaking at scientific symposia sponsored by Sanofi Aventis, Boehringer Ingelheim, Bristol Myers Squibb and Pfizer. He has also consulted on advisory boards.